For people with diabetes taking glucose-lowering medications: Medication review : Your healthcare team should review and potentially reduce doses of insulin or sulphonylureas before starting Wegovy Blood glucose monitoring : Increase the frequency of self-monitoring, particularly before meals and at bedtime, especially during dose escalation Recognise patterns : Keep a diary noting blood glucose readings, meal times, and any symptoms to identify trends Adjust insulin doses : Work with your diabetes team to establish protocols for insulin dose adjustments based on readings and food intake Carry glucose : Always have fast-acting carbohydrates available (glucose tablets, juice, or sweets) to treat hypoglycaemia promptly For treating hypoglycaemia (for all at risk): Take 15-20g of fast-acting carbohydrate (e.g., 4-5 glucose tablets, 150-200ml fruit juice, or 5-6 jelly babies) Recheck blood glucose after 10-15 minutes If still below 4.0 mmol/L, repeat the fast-acting carbohydrate Once recovered, eat a longer-acting carbohydrate snack or meal (e.g., sandwich, cereal, or fruit with crackers) Those at risk of severe hypoglycaemia should have glucagon available and ensure family members know how to use it For people without diabetes: Regular meals : Despite reduced appetite, maintain a regular eating pattern with balanced meals containing adequate carbohydrates Recognise symptoms : Be aware of hypoglycaemia symptoms and don't dismiss them as general unwellness Avoid prolonged fasting : Whilst Wegovy reduces hunger, extended periods without food may trigger low blood sugar in susceptible individuals Moderate alcohol : Limit alcohol consumption and always consume it with food General strategies for all patients: Ensure adequate hydration, as Wegovy can cause gastrointestinal side effects that may affect fluid balance

olive), and in the sebum (the oily stuff our skin produces) of the human skin
Third-party tested Every batch
Safety Adverse effects No serious adverse effects of isothiocyanates in humans have been reported
Most professional organizations and regulatory bodies recommend against GLP-1 use during breastfeeding, not because of proven danger, but because of insufficient data to confirm safety definitively
Report any concerns to your vet immediately